Green Vegetables and Women's Health

NCT ID: NCT01726127

Last Updated: 2015-10-07

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 66 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2012-11-30
• Study Completion Date: 2015-09-30

Brief Summary

The 2010 Dietary Guidelines for Americans recommend that individuals consume 4.5 to 5 cups fruits and vegetables daily. However, at current intake levels, fruit consumption will have to improve by more than 100% and vegetable intake by 50% to meet this recommendation. Importantly, intake of brightly colored fruits and vegetables is even lower when potatoes are not considered. It is possible that improved fruit and vegetable intake will have beneficial health effects. For example, higher intakes of fruits and vegetables, and particularly cruciferous vegetables (e.g., broccoli, Brussels sprouts, cauliflower, etc.), are associated with lower rates of many degenerative diseases, including some cancers, yet this group of vegetables may continue to be under-consumed due to their strong flavors. A supplement made from these vegetables (Cruciferous CompleteTM made by Standard Process Inc. Palmyra, WI) contains a group of phytochemicals called glucosinolates that can shift estrogen metabolism in a favorable way. One proposed biomarker of chemoprotection from breast cancer is the urinary estrogen metabolite ratio of 2- to 16α-hydroxyestrogens (2:16). In the main study, the effects of cruciferous vegetables (broccoli or Brussels sprouts), Cruciferous CompleteTM whole food supplements, or placebos on this ratio of urinary estrogen metabolites in healthy premenopausal women will be compared over an eight-week period. The investigators hypothesize that treatment with daily supplements will increase the 2:16 ratio as compared to daily consumption of a combination of Brussels sprouts and broccoli or a placebo, suggesting reduced breast cancer risk.

In a sub-study, the relationships between serum α-carotene, β-carotene, β-cryptoxanthin, lutein and lycopene with dietary carotenoid intake as measured by a food frequency questionnaire and body composition will be evaluated in healthy premenopausal women. Carotenoids are a family of lipophilic compounds found primarily in colorful plant tissues and their concentration in human blood reflects dietary intake of carotenoid-rich foods. Carotenoid levels in the blood of healthy women do not appear to be influenced by menstrual status, but are inversely associated with body fatness. Thus, serum carotenoid concentrations may serve as a functional marker for chronic disease risk associated with excess body fat.

Conditions

Dietary Modification

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SCREENING
• Blinding Strategy: TRIPLE

Study Groups

Broccoli and Brussels Sprouts

Subjects will consume broccoli or Brussels sprouts (40g daily) for 8 weeks.

Group Type: EXPERIMENTAL

Broccoli and Brussels Sprouts

Intervention Type: OTHER

Cruciferous Complete

Subjects will take Cruciferous CompleteTM supplements (2 capsules, 3 times daily) for 8 weeks.

Group Type: EXPERIMENTAL

Cruciferous Complete

Intervention Type: DIETARY_SUPPLEMENT

Placebo

Subjects will take placebo capsules (2 capsules, 3 times daily) for 8 weeks.

Group Type: PLACEBO_COMPARATOR

Placebo

Intervention Type: OTHER

Interventions

Broccoli and Brussels Sprouts

Intervention Type: OTHER

Cruciferous Complete

Intervention Type: DIETARY_SUPPLEMENT

Placebo

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Premenopausal women between the ages of 40-50; premenopause is defined as regular menstrual cycles every 23-35 days
• Willing to be randomized and compliant to the 3 study groups (whole cruciferous vegetable intake, cruciferous supplement or placebo capsules)
• Able to give informed consent.

Exclusion Criteria

• Urinary 2:16 > or = 3.
• Current kidney or liver disease, adrenalectomy, or oophorectomy.
• Use of tobacco products within the preceding three months, illegal use of medications or use of illegal drugs or substances.
• Current use of antibiotics, cimetidine or black cohosh.
• Systemic administration of estrogen, or use of non-prescription hormones, tamoxifen, or diabetes medication within the last three months.
• Women under a physician-directed diet or those with a strong dislike of Brassica vegetables.
• Presence of cancer in the last 5 years, with the exception of fully resected basal or squamous cell tumors.
• Participation in an investigational drug study in the last 30 days.

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 50 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Standard Process Inc.

INDUSTRY

Sponsor Role: collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sherry A. Tanumihardjo, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Neil Binkley, MD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

University of Wisconsin Osteoporosis Clinical Research Program Clinic

Madison, Wisconsin, United States

Countries

United States

Other Identifiers

2011-0872

Identifier Type: -

Identifier Source: org_study_id